New FDA approvals in epilepsy, fertility, and heart failure

Three medical device clearances, new GLP-1 side-effect signals, and a UK-France biomedical alliance mark this week's health landmark.

• Friday, 30 May: ECoG Assistant Brings AI to Epilepsy Brain Monitoring
• Thursday, 29 May: Non-Invasive Wearable Sensor Estimates Heart-Failure Pressure
• Thursday, 29 May: IVF Embryo-Selection AI Cleared on Randomised Trial Evidence
• Thursday, 29 May: Penn Study Surfaces Overlooked GLP-1 Side Effects Via Social Media
• Thursday, 29 May: AstraZeneca and Nucs AI Target Prostate Cancer Response Prediction
• Thursday, 29 May: Oxford and Institut Pasteur Launch Cross-Border Biomedical Alliance
• Friday, 30 May: Colorado Restricts AI in Psychotherapy and Mandates Crisis Referral